Breaking News

Althea, Profectus in Plasmid Production Pact

Althea to provide cGMP plasmid DNA for vaccine development

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Althea Technologies and Profectus BioSciences have signed a manufacturing supply agreement for plasmid DNA production. Althea will provide gram-scale quantities of cGMP-manufactured plasmid DNA expressing IL-12 for Profectus Biosciences’ ongoing DNA vaccine development efforts. IL-12 is designed to prompt an immune response once the DNA enters a cell, which is part of Profectus Biosciences’ technology platform to overcome the poor delivery and immunogenicity of DNA vaccines.   &#8220...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters